Pharmacoeconomic Aspects of Antibacterial Therapy with Azithromycin of Community-Acquired Pneumonia in Servicemen

Author： Dzyublyk Olexander Y.   Mukhin Olexander O.   Simonov Sergey S.  

Publisher： Haworth Press

ISSN： 1068-7777

Source： Journal of Infectious Disease Pharmacotherapy, Vol.6, Iss.3, 2004-01, pp. : 31-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Pharmacological Therapy for Community-Acquired Pneumonia: The Role of Dual Antibacterial Therapy

By Epstein Benjamin J.   Gums John G.  

Drugs, Vol. 65, Iss. 14, 2005-01 ,pp. : 1949-1971

Adis International

Access to resources Recommend Favorite

Short- versus Long-Course Antibacterial Therapy for Community-Acquired Pneumonia: A Meta-Analysis

By Dimopoulos George   Matthaiou Dimitrios K.  

Drugs, Vol. 68, Iss. 13, 2008-01 ,pp. : 1841-1854

Adis International

Access to resources Recommend Favorite

Community-Acquired Pneumonia in Children: Issues in Optimizing Antibacterial Treatment

By Korppi M.  

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 821-832

Adis International

Access to resources Recommend Favorite

Base the antibacterial treatment of community-acquired pneumonia on disease severity and other factors

By  

Drugs & Therapy Perspectives, Vol. 28, Iss. 5, 2012-05 ,pp. : 15-19

Adis International

Access to resources Recommend Favorite

Tigecycline: In Community-Acquired Pneumonia

By McKeage Kate   Keating Gillian M.  

Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. : 2633-2644

Adis International

Access to resources Recommend Favorite